Can fatty liver in children lead to serious liver disease? a Long-Term study aims to find out

NCT ID NCT03190538

Recruiting now Knowledge-focused Sponsor: Humanity and Health Research Centre Source: ClinicalTrials.gov ↗

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This study follows children aged 1 to 18 with biopsy-confirmed nonalcoholic fatty liver disease (NAFLD) to track how the condition changes over time. Researchers will monitor for liver-related death, cirrhosis complications, and the need for liver transplants. The goal is to better understand which children are at risk for severe liver problems and how the disease progresses.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors predict which children with fatty liver disease are at risk for serious liver problems.
What could go wrong: This is an observational study, so it cannot test treatments. It may take many years to see clear patterns, and results may not apply to all children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-ALCOHOLIC FATTY LIVER DISEASE

Contacts and locations

Locations

Children's Liver Disease Center, 302 Hospital
RECRUITING

Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.